Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells
出版年份 2019 全文链接
标题
Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells
作者
关键词
-
出版物
Cancers
Volume 11, Issue 5, Pages 703
出版商
MDPI AG
发表日期
2019-05-23
DOI
10.3390/cancers11050703
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
- (2018) Nicholas Thomford et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
- (2018) Kamil Lisek et al. Oncotarget
- Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
- (2018) Ramona Schulz-Heddergott et al. Cancers
- EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation
- (2018) M.S. Gilardini Montani et al. Autophagy
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- The role of cellular reactive oxygen species in cancer chemotherapy
- (2018) Haotian Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
- (2017) Aleksandra Adamska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action
- (2017) Thazin Aung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
- (2017) Marisa Granato et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
- (2017) Maria Saveria Gilardini Montani et al. CELLULAR ONCOLOGY
- Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
- (2017) Xiaohui Yan et al. Cell and Bioscience
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Health functionality of apigenin: A review
- (2016) Fahad Ali et al. INTERNATIONAL JOURNAL OF FOOD PROPERTIES
- Reactivation of mutant p53 by capsaicin, the major constituent of peppers
- (2016) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
- (2016) Marco Cordani et al. Molecular Oncology
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- Cancer drug resistance: redox resetting renders a way
- (2016) Yuan Liu et al. Oncotarget
- p62 links autophagy and Nrf2 signaling
- (2015) Tao Jiang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Zn(II)-curc targets p53 in thyroid cancer cells
- (2015) ALESSIA GARUFI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection
- (2015) Sharadha Dayalan Naidu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A dual role of p53 in the control of autophagy
- (2014) Ezgi Tasdemir et al. Autophagy
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)
- (2014) Zuzana Sol�rov� et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
- (2014) D Li et al. Cell Death & Disease
- Degradation of mutant p53H175 protein by Zn(II) through autophagy
- (2014) A Garufi et al. Cell Death & Disease
- The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma
- (2013) M. Chatterjee et al. HAEMATOLOGICA
- A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
- (2013) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53R273Hattenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
- (2012) Eyal Kalo et al. JOURNAL OF CELL SCIENCE
- Evidence for activation of mutated p53 by apigenin in human pancreatic cancer
- (2011) Jonathan C. King et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
- (2011) Ming Zhao et al. Molecular Cancer
- p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
- (2010) Ashish Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
- (2008) Sanjeev Shukla et al. FREE RADICAL BIOLOGY AND MEDICINE
- Chaperone-dependent stabilization and degradation of p53 mutants
- (2008) P Muller et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started